Nucaps Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
18
Nucaps General Information
Description
Developer of an encapsulation technology designed for the industrial development of nanocapsules and biocapsules for bioactive and probiotics. The company's technology is based on the use of food proteins such as casein, zein, or soy for the oral delivery and controlled release of drugs or actives and microorganisms, enabling clients to achieve the protection and improvement of the active ingredients introduced into the capsules.
Contact Information
Website
www.nucapsnanotechnology.comCorporate Office
- Polígono Mocholi, Vivero CEIN
- Nave R2, Noáin
- 31110 Pamplona
- Spain
Corporate Office
- Polígono Mocholi, Vivero CEIN
- Nave R2, Noáin
- 31110 Pamplona
- Spain
Nucaps Timeline
Nucaps Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Accelerator/Incubator | 01-May-2026 | Completed | Generating Revenue | |||
| 14. Accelerator/Incubator | 04-Apr-2024 | Completed | Generating Revenue | |||
| 13. Later Stage VC | 21-Nov-2023 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 01-Jun-2023 | Completed | Generating Revenue | |||
| 11. Accelerator/Incubator | 25-May-2023 | Completed | Generating Revenue | |||
| 10. Seed Round | 22-Feb-2023 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 8. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 7. Grant | 29-Jun-2021 | $187K | $709K | Completed | Generating Revenue | |
| 6. Seed Round | 17-Mar-2020 | $440K | $709K | Completed | Generating Revenue |
Nucaps Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 752 | $1.078260 | $344.13 | $344.13 | 1x | $344.13 | 10.37% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nucaps Patents
Nucaps Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025242779-A1 | Particles for embedding active substances, capsules and process for obtaining them | Pending | 23-May-2024 | ||
| US-20240342234-A1 | Encapsulated phytomedicines for use against cancer | Pending | 13-Apr-2023 |
Nucaps Signals
Nucaps Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Space F | Accelerator/Incubator | |||
| RootCamp | Accelerator/Incubator | |||
| Corporación Alimentaria Peñasanta (Spanish) | Corporate Venture Capital | Minority | ||
| Sociedad de Desarrollo de Navarra | Venture Capital | Minority | ||
| Socialnest | Accelerator/Incubator |
Nucaps FAQs
-
When was Nucaps founded?
Nucaps was founded in 2016.
-
Where is Nucaps headquartered?
Nucaps is headquartered in Pamplona, Spain.
-
What is the size of Nucaps?
Nucaps has 18 total employees.
-
What industry is Nucaps in?
Nucaps’s primary industry is Biotechnology.
-
Is Nucaps a private or public company?
Nucaps is a Private company.
-
What is Nucaps’s current revenue?
The current revenue for Nucaps is .
-
How much funding has Nucaps raised over time?
Nucaps has raised $1.7M.
-
Who are Nucaps’s investors?
Space F, RootCamp, Corporación Alimentaria Peñasanta (Spanish), Sociedad de Desarrollo de Navarra, and Socialnest are 5 of 18 investors who have invested in Nucaps.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process